Transcription factor modulating compounds and methods of use thereof

Details for Australian Patent Application No. 2007351886 (hide)

Owner Paratek Pharmaceuticals, Inc.

Inventors Kim, Oak K.

Agent Watermark

Pub. Number AU-A-2007351886

PCT Pub. Number WO2008/130368

Priority 60/815,984 23.06.06 US

Filing date 25 June 2007

Wipo publication date 30 October 2008

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4184 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

C07D 235/22 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07F 9/6506 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/130368 Priority application(s): WO2008/130368

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007351891-Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same

2007351866-Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases